A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage damaged p53. This crucial tumor protector protein is frequently disabled in many types of tumors, resulting uncontrolled cell https://thefairlist.com/story12225086/nanobodies-revive-p53-a-promising-approach-for-tumor-treatment